Healthcare services company CVS Health (NYSE: CVS) has updated its 2025 full-year financial guidance and provided 2026 full-year financial guidance.
- The company raised its revenue guidance for fiscal 2025 to at least $400.0 billion from the earlier forecast of $397.3 billion
- The outlook for FY25 adjusted earnings per share has been increased $6.60-$6.70 from $6.55-$6.65 estimated earlier
- It also reaffirmed its fiscal 2025 cash flow from operations guidance range of $7.5 billion to $8.0 billion
- For fiscal 2026, the management forecasts total revenues of at least $400.0 billion
- It sees FY26 earnings per share in the range of $5.94 to $6.14, and adjusted earnings per share between $7.00 and $7.20
- FY26 operating income is expected to be in the range of $13.26 billion to $13.60 billion, and adjusted operating income in the $15.07-$15.41 billion range
- Cash flow from operations is expected to be at least $10.0 billion in fiscal 2026
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Campbell’s Company (CPB) Q1 adj. earnings beat estimates; sales down 3%
The Campbell’s Company (NASDAQ: CPB) on Tuesday announced results for the first quarter of fiscal 2026, reporting a year-over-year decline in sales and adjusted profit. However, earnings topped Wall Street's
AutoZone (AZO) Q1 2026 Earnings: Key financials and quarterly highlights
AutoZone, Inc. (NYSE: AZO) reported its first quarter 2026 earnings results today. Net sales were $4.6 billion, up 8.2% from the same period a year ago. Same store sales were up
Earnings Preview: General Mills (GIS) projected to report lower sales and earnings for Q2 2026
Shares of General Mills, Inc. (NYSE: GIS) stayed green on Monday. The stock has dropped 8% over the past three months. The branded foods company is scheduled to report its
